Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 27, Issue 12, Pages 3552-3559Publisher
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2015101108
Keywords
-
Categories
Funding
- Diabetes Research and Training Center - National Institutes of Health (NIH) [DK20572]
- O'Brien Renal Core Center - National Institutes of Health (NIH) [P30-DK08194]
- NIH [DK099434, DK068306]
Ask authors/readers for more resources
Karyomegalic interstitial nephritis (KIN) is a chronic interstitial nephropathy characterized by tubulointerstitial nephritis and formation of enlarged nuclei in the kidneys and other tissues. We recently reported that recessive mutations in the gene encoding FANCD2/FANCI-associated nuclease 1 (FAN1) cause KIN in humans. FAN1 is a major component of the Fanconi anemia-related pathway of DNA damage response (DDR) signaling. To study the pathogenesis of KIN, we generated a Fan1 knockout mouse model, with abrogation of Fan1 expression confirmed by quantitative RT-PCR. Challenging Fan1(-/-) and wild-type mice with 20 mg/kg cisplatin caused AKI in both genotypes. In contrast, chronic injection of cisplatin at 2 mg/kg induced KIN that led to renal failure within 5 weeks in Fan1(-/-) mice but not in wild-type mice. Cell culture studies showed decreased survival and reduced colony formation of Fan1(-/-) mouse embryonic fibroblasts and bone marrow mesenchymal stem cells compared with wild type counterparts in response to treatment with genotoxic agents, suggesting that FAN1 mutations cause chemosensitivity and bone marrow failure. Our data show that Fan1 is involved in the physiologic response of kidney tubular cells to DNA damage, which contributes to the pathogenesis of CKD. Moreover, Fan1(-/-) mice provide a new model with which to study the pathomechanisms of CKD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available